BSPK / Bespoke Extracts, Inc. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Bespoke Extracts, Inc.
US ˙ OTCPK

Mga Batayang Estadistika
CIK 1409197
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Bespoke Extracts, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
August 27, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, IN

August 14, 2025 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ý Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on Fo

July 7, 2025 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2025 Bespoke Extracts, Inc.

July 7, 2025 EX-99.1

Balance Sheet Condensed Consolidated Balance Sheets

Exhibit 99.1 Bespoke Extracts, Inc. Announces Financial Results and Strategic Rebranding for the First Quarter Ended March 31, 2025 Aurora, CO – June 30, 2025 – Bespoke Extracts, Inc. (OTCQB: BSPK), a Colorado based company focused on operating in the regulated cannabis markets in the United States, today announced its financial results for the first quarter ended March 31, 2025, and highlighted t

June 30, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, I

May 15, 2025 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2025 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo

May 9, 2025 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2025 Bespoke Extracts, Inc.

May 9, 2025 EX-16.1

Letter from Assurance Dimensions addressed to the Securities and Exchange Commission dated May 8, 2025

Exhibit 16.1 Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 May 8, 2025 To whom it may concern: We have read the notification dated May 8, 2025 from Bespoke Extracts, Inc. as to the replacement of auditors for that Company. We agree with the representations of the Company, as follows: 1. During the previous year with Assurance Dimensions, there were no problems related to

April 21, 2025 EX-21.1

Subsidiaries: Bespoke Extracts Colorado, LLC (Colorado)

Exhibit 21.1 Subsidiaries: Bespoke Extracts Colorado, LLC (Colorado)

April 21, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (E

March 31, 2025 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report o

February 19, 2025 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2024 Bespoke Extracts, Inc.

February 19, 2025 EX-10.1

Agreement for Conversion of Amounts Owed to Promissory Note and Agreement to Amend Lease

Exhibit 10.1 Agreement for Conversion of Amounts Owed to Promissory Note and Agreement to Amend Lease This Agreement is made effective as of December 31, 2024 between WL Holdings, LTD ("Landlord") and Bespoke Extracts Colorado, LLC ("the Company"). WHEREAS: The Company and the Landlord are both parties to that certain lease dated December 2, 2021 (the "Lease"): The Company is the holder of certain

February 19, 2025 EX-10.2

Promissory Note

Exhibit 10.2 PROMISSORY NOTE Principal Amount: $169,000 WHEREAS: Bespoke Extracts Colorado, LLC (the “Company”) and WL Holdings, LTD (“Holder”) are both parties to that certain lease dated December 2, 2021 (the “Lease”). The Company is currently indebted to the Holder for the total amount of $169,000 and promises to pay such amount to the Holder. The Holder has agreed to accept this Note in cancel

December 26, 2024 EX-10.1

Form of Purchase Agreement

Exhibit 10.1 BESPOKE EXTRACTS, INC. DECEMBER 2024 Securities PURCHASE AGREEMENT BESPOKE EXTRACTS, INC. DECEMBER 2024 Securities PURCHASE AGREEMENT This Securities Purchase Agreement (the “Agreement”) is made as of the 18th day of December 2024 by and between BESPOKE EXTRACTS, INC., a Nevada corporation (the “Company”) and the Purchasers identified on the signature pages hereto (each a “Purchaser”

December 26, 2024 EX-10.2

Form of Note

Exhibit 10.2 EXHIBIT A THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND SUCH STATE SECURITIES LAWS, OR AN EXEMPTION FROM REGISTRATION THEREUNDER, IN EACH CASE, TO THE EXTENT APPLICABLE HERETO. DECEMBER 2024 SENIOR

December 26, 2024 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 18, 2024 Bespoke Extracts, Inc.

December 26, 2024 EX-10.3

Form of Warrant

Exhibit 10.3 EXHIBIT B FORM OF WARRANT NEITHER THIS WARRANT NOR THE SECURITIES FOR WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUAN

November 13, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2024 ☐ TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACT

October 8, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, IN

August 14, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K ☒ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2024 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo

July 2, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, I

May 14, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2024 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo

April 18, 2024 EX-21.1

Subsidiaries: Bespoke Extracts Colorado, LLC (Colorado)

Exhibit 21.1 Subsidiaries: Bespoke Extracts Colorado, LLC (Colorado)

April 18, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (E

April 1, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ýForm 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on

February 20, 2024 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2024 Bespoke Extracts, Inc.

February 20, 2024 EX-10.1

Form of Purchase Agreement (incorporated by reference to 8-K filed February 20, 2024)

Exhibit 10.1 BESPOKE EXTRACTS, INC. 2024 Securities PURCHASE AGREEMENT This Securities Purchase Agreement (the “Agreement”) is made as of the day of February 2024 by and between BESPOKE EXTRACTS, INC., a Nevada corporation (the “Company”) and the Purchasers identified on the signature pages hereto (each a “Purchaser” and together the “Purchasers”). RECITALS The Company desires to issue and sell, a

February 20, 2024 EX-10.2

Form of Note (incorporated by reference to 8-K filed February 20, 2024)

Exhibit 10.2 EXHIBIT A THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND SUCH STATE SECURITIES LAWS, OR AN EXEMPTION FROM REGISTRATION THEREUNDER, IN EACH CASE, TO THE EXTENT APPLICABLE HERETO. SENIOR SECURED NOTE

February 20, 2024 EX-10.3

Form of Warrant (incorporated by reference to 8-K filed February 2024)

Exhibit 10.3 COMMON STOCK PURCHASE WARRANT BESPOKE EXTRACTS, INC. Warrant # 2024-x: Issue Date: February 16 2024 Warrant Shares + Initial Exercise Date: February 16 2024 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth,

January 16, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 ☐ TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACT

November 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report

September 28, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, IN

September 28, 2023 EX-10.1

Senior Note*

Exhibit 10.1 THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND SUCH STATE SECURITIES LAWS, OR AN EXEMPTION FROM REGISTRATION THEREUNDER, IN EACH CASE, TO THE EXTENT APPLICABLE HERETO. SENIOR NOTE $849,500.00 Septem

August 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K ☒ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: June 30, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo

July 14, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, I

May 15, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K ýForm 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: March 31, 2023 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on Fo

April 27, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (E

April 3, 2023 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ýForm 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: December 31, 2022 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on

January 9, 2023 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2023 Bespoke Extracts, Inc.

December 15, 2022 DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. )

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ? Preliminary Information Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ? Definitive Information Statement Bespoke Extracts, Inc. (Name of

December 5, 2022 PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. )

PRE 14C 1 ea169645-pre14cbespoke.htm PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)

November 21, 2022 EX-10.1

Termination Agreement

Exhibit 10.1 TERMINATION AGREEMENT This TERMINATION AGREEMENT (this ?Agreement?), dated November 18, 2022 (the ?Effective Date?), made by and between Osiris, LLC, a Colorado limited liability company (?Seller?) and Michael Gurtman (?Owner?), on the one hand, and Bespoke Extracts Colorado, LLC, a Colorado limited liability company (?Buyer?) and Bespoke Extracts, Inc., a Nevada corporation (?Parent?

November 21, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 ☐ TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACT

November 16, 2022 EX-10.1

Amendment No. 1 to Inventory Earn Out Agreement (incorporated by reference to 8-K filed November 16, 2022)

Exhibit 10.1 AMENDMENT NO. 1 TO INVENTORY EARN OUT AGREEMENT This Amendment No. 1 to Inventory Earn Out Agreement (this “Amendment”) dated this 11th day of November, 2022, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Berique Labs, LLC, a Florida limited liability company (the “Lender”). WHEREAS, the Company and the Lender are party to an inventory earn out agreemen

November 16, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2022 Bespoke Extracts, Inc.

November 14, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: September 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report

November 7, 2022 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2022 Bespoke Extracts, Inc.

November 7, 2022 EX-16.1

Letter from Liggett & Webb, P.A. (incorporated by reference to 8-K filed November 7, 2022)

Exhibit 16.1 November 7, 2022 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 RE: Bespoke Extracts, Inc. File Ref No: 000-52759 We have read the statements of Bespoke Extracts, Inc., pertaining to our firm included under Item 4.01 of Form 8-K dated October 27, 2022 and agree with such statements as they pertain to our firm. We have read Item 4.01, captioned ?Changes in

November 3, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 31, 2022 Bespoke Extracts, Inc.

November 3, 2022 EX-10.1

Amendment No. 4 to Asset Purchase Agreement (incorporated by reference to 8-K filed November 3, 2022)

Exhibit 10.1 AMENDMENT TO ASSET PURCHASE AGREEMENT This Amendment No. 4 (?Amendment No. 4?) is made as of October 31, 2022 to the Asset Purchase Agreement (the ?Agreement?), dated as of December 2, 2021, by and between WonderLeaf, LLC, a Colorado limited liability company (?Seller?), and Bespoke Extracts Colorado, LLC (?Buyer?). Capitalized terms not herein defined shall have the meaning ascribed

October 18, 2022 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 17, 2022 Bespoke Extracts, Inc.

October 11, 2022 EX-99.1

Bespoke Extracts, Inc. Receives Regulatory Approval from Colorado Marijuana Enforcement Division Approval qualifies Bespoke to acquire licensed cannabis operations throughout Colorado

Exhibit 99.1 Bespoke Extracts, Inc. Receives Regulatory Approval from Colorado Marijuana Enforcement Division Approval qualifies Bespoke to acquire licensed cannabis operations throughout Colorado Denver, CO (October 6, 2022)?Bespoke Extracts, Inc. (OTCQB: BSPK) today announced that the Colorado Marijuana Enforcement Division (MED) has approved Bespoke?s application for ?Suitability?. This approva

October 11, 2022 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 6, 2022 Bespoke Extracts, Inc.

September 9, 2022 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 8, 2022 Bespoke Extracts, Inc.

September 9, 2022 EX-10.1

Amendment No. 3 to Asset Purchase Agreement (incorporated by reference to 8-K filed September 9, 2022)

Exhibit 10.1 AMENDMENT TO ASSET PURCHASE AGREEMENT This Amendment No. 2 (?Amendment No. 2?) is made as of August 30, 2022 to the Asset Purchase Agreement (the ?Agreement?), dated as of December 2, 2021, by and between WonderLeaf, LLC, a Colorado limited liability company (?Seller?), and Bespoke Extracts Colorado, LLC (?Buyer?). Capitalized terms not herein defined shall have the meaning ascribed t

August 19, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, IN

August 17, 2022 EX-10.1

Form of Purchase Agreement

Exhibit 10.1 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (the ?Agreement?) is entered into on August 11, 2022, by and between Osiris, LLC, a Colorado limited liability company (?Seller?) and Michael Gurtman (?Owner?), on the one hand, and Bespoke Extracts Colorado, LLC, a Colorado limited liability company (?Buyer?) and Bespoke Extracts, Inc., a Nevada corporation (?Parent?) on the othe

August 17, 2022 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 11, 2022 Bespoke Extracts, Inc.

August 17, 2022 EX-99.1

Bespoke Extracts to Expand its Colorado Business and Capabilities with Acquisition of Best Day Ever Acquisition will create a vertically integrated Colorado cannabis company, significantly accelerating Bespoke’s growth strategy

Exhibit 99.1 Bespoke Extracts to Expand its Colorado Business and Capabilities with Acquisition of Best Day Ever Acquisition will create a vertically integrated Colorado cannabis company, significantly accelerating Bespoke?s growth strategy DENVER and ASPEN, Aug. 12, 2022 (GLOBE NEWSWIRE) - Bespoke Extracts, Inc. (?Bespoke?) (OTCQB: BSPK) and Osiris, LLC doing business as Best Day Ever (?BDE?) tod

August 15, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: June 30, 2022 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report on Fo

July 7, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2022 Bespoke Extracts, Inc.

July 7, 2022 EX-3.1

Amendment to Bylaws (incorporated by reference to 8-K filed July 7, 2022)

Exhibit 3.1 Amendment No. 1 To Bylaws of Bespoke Extracts, Inc. Adopted July 7, 2022 The Bylaws of Bespoke Extracts, Inc. are hereby amended by the addition of the following Article XIII: ARTICLE XIII: DIVESTITURE PLAN Section 13.1. UNSUITABLE OR PROHIBITED BENEFICIAL OWNERS. So long as the Corporation holds (directly or indirectly) a license from a governmental agency to conduct its business, whi

July 7, 2022 EX-10.1

Amendment No. 2 to Asset Purchase Agreement (incorporated by reference to 8-K filed July 7, 2022)

Exhibit 10.1 AMENDMENT TO ASSET PURCHASE AGREEMENT This Amendment No. 2 (?Amendment No. 2?) is made as of June 30, 2022 to the Asset Purchase Agreement (the ?Agreement?), dated as of December 2, 2021, by and between WonderLeaf, LLC, a Colorado limited liability company (?Seller?), and Bespoke Extracts Colorado, LLC (?Buyer?). Capitalized terms not herein defined shall have the meaning ascribed the

May 16, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, I

April 15, 2022 SC 13D/A

BSPK / Bespoke Extracts Inc / FEINSOD MICHAEL - AMENDMENT NO. 2 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

April 1, 2022 8-K

Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2022 Bespoke Extracts, Inc.

March 24, 2022 10-QT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: ☒ TRANSITION REPORT PURSUANT TO SECTION 13 OR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☐ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: or ☒ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from September 1, 2021 to December 31, 2021 Commission File Number: 000-5275

March 21, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 10-Q 1 ea157171-nt10qbespoke.htm NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K x Transition Report on Form 10-Q ¨ Transition

February 4, 2022 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 2, 2022 Bespoke Extracts, Inc.

January 19, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2021 ☐ TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

January 14, 2022 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: November 30, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q ? Transition Report o

January 3, 2022 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 27, 2021 Bespoke Extracts, Inc.

January 3, 2022 EX-10.2

Form of Warrant (incorporated by reference to 8-K filed January 3, 2022)

Exhibit 10.2 Form of Warrant NEITHER THIS WARRANT NOR THE SECURITIES FOR WHICH THIS WARRANT IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EF

January 3, 2022 EX-10.1

Form of Purchase Agreement (incorporated by reference to 8-K filed January 3, 2022)

Exhibit 10.1 BESPOKE EXTRACTS, INC. Securities PURCHASE AGREEMENT This Securities Purchase Agreement (the ?Agreement?) is made as of the day of December 2021 by and between BESPOKE EXTRACTS, INC.., a Nevada corporation (the ?Company?) and the Purchasers identified on the signature pages hereto (each a ?Purchaser? and together the ?Purchasers?). RECITALS The Company desires to issue and sell, and e

December 17, 2021 SC 13D/A

BSPK / Bespoke Extracts Inc / FEINSOD MICHAEL - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

December 16, 2021 SC 13D

BSPK / Bespoke Extracts Inc / Garth Tyler Hunter - SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC.

December 15, 2021 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 14, 2021 Bespoke Extracts, Inc.

December 15, 2021 EX-10.4

Form of Restricted Stock Award Agreement (incorporated by reference to 8-K filed December 15, 2021)

Exhibit 10.4 Restricted Stock Award Agreement This Restricted Stock Award Agreement (this ?Agreement?) is made and entered into as of December 14, 2021 (the ?Grant Date?) by and between Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and (the ?Grantee?). WHEREAS, the Company has adopted the 2021 Equity Incentive Plan (the ?Plan?) pursuant to which awards of Restricted Stock may be gra

December 15, 2021 EX-10.5

Form of Option Agreement (incorporated by reference to 8-K filed December 15, 2021)

Exhibit 10.5 Non-Qualified Stock Option Agreement This Stock Option Agreement (this "Agreement") is made and entered into as of December 14, 2021 by and between Bespoke Extracts, Inc., a Nevada corporation (the "Company") and (the "Participant"). Grant Date: December 14, 2021 Exercise Price per Share: Number of Option Shares: Expiration Date: December 14, 2031 1. Grant of Option. 1.1 Grant; Type o

December 15, 2021 EX-10.3

Bespoke Extracts, Inc. 2021 Equity Incentive Plan (incorporated by reference to 8-K filed December 15, 2021)

Exhibit 10.3 BESPOKE EXTRACTS, INC. 2021 EQUITY INCENTIVE PLAN 1. Purpose; Eligibility. 1.1 General Purpose. The purpose of the Plan is to promote the long-term success of the Company and the creation of stockholder value by (a) encouraging Participants to focus on the Company?s performance and growth, (b) encouraging the attraction and retention of Participants with exception qualifications, and

December 15, 2021 EX-10.2

Employment Agreement, dated December 14, 2021, between the Company and Hunter Garth (incorporated by reference to 8-K filed December 15, 2021) ***

Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is dated as of December 14, 2021 by and between Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and Hunter Garth (the ?Executive?) (together, the ?Parties?). RECITALS WHEREAS, the Parties wish to document the continuing role of the Executive as a director of the Company (the ?Board?) and document the new role of

December 15, 2021 EX-10.1

Employment Agreement, dated December 14, 2021, between the Company and Michael Feinsod (incorporated by reference to 8-K filed December 15, 2021) ***

Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (?Agreement?) is dated as of December 14, 2021 by and between Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and Michael Feinsod (the ?Executive?) (together, the ?Parties?). RECITALS WHEREAS, the Parties wish to document the continuing role of the Executive as the Executive Chairman of the Board of Directors of the Company (

December 15, 2021 EX-99.1

Building a Portfolio of Premium Cannabis and CBD Assets Wonderleaf Acquisition Update December 14, 2021 This presentation and other written or oral statements made from time to time by representatives of Bespoke Extracts, Inc. co nta in “forward - lo

Exhibit 99.1 Building a Portfolio of Premium Cannabis and CBD Assets Wonderleaf Acquisition Update December 14, 2021 This presentation and other written or oral statements made from time to time by representatives of Bespoke Extracts, Inc. co nta in ?forward - looking statements? within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange

December 13, 2021 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (Exa

December 8, 2021 EX-10.1

Asset Purchase Agreement, dated December 2, 2021, between Bespoke Extracts Colorado, LLC and WonderLeaf, LLC (incorporated by reference to 8-K filed December 8, 2021)

Exhibit 10.1 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (the ?Agreement?) is entered into on December 2, 2021, by and between WonderLeaf, LLC, a Colorado limited liability company (?Seller?), and Bespoke Extracts Colorado, LLC (?Buyer?). Seller and Buyer are sometimes referred to individually as a ?Party? and collectively as the ?Parties.? Recitals A. Seller is in the business of proce

December 8, 2021 EX-10.3

Lease, dated December 2, 2021, between Bespoke Extracts Colorado, LLC and WL Holdings, Ltd. (incorporated by reference to 8-K filed December 8, 2021)

Exhibit 10.3 LEASE AGREEMENT THIS LEASE AGREEMENT (?Lease?) is entered into the 2nd day of December 2021, by and between WL Holdings, Ltd., a Colorado limited liability company (?Landlord?) and Bespoke Extracts Colorado, LLC, a Colorado limited liability company (?Tenant?). WITNESSETH: ARTICLE I PREMISES 1.1 Lease of Premises. In consideration of the Rent to be paid and the covenants and agreement

December 8, 2021 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2021 Bespoke Extracts, Inc.

December 8, 2021 EX-10.2

Amendment No. 1 to Asset Purchase Agreement between Bespoke Extracts Colorado, LLC and WonderLeaf, LLC (incorporated by reference to 8-K filed December 8, 2021)

Exhibit 10.2 AMENDMENT TO ASSET PURCHASE AGREEMENT This Amendment No. 1 (?Amendment No. 1?) is made as of December 7, 2021 to the Asset Purchase Agreement (the ?Agreement?), dated as of December 2, 2021, by and between WonderLeaf, LLC, a Colorado limited liability company (?Seller?), and Bespoke Extracts Colorado, LLC (?Buyer?). Capitalized terms not herein defined shall have the meaning ascribed

December 8, 2021 EX-99.1

Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC

Exhibit 99.1 Bespoke Extracts to Acquire Colorado Based Wonderleaf, LLC Transaction provides Bespoke with a licensed marijuana infused production facility in Colorado. DENVER, Colorado., Dec. 02, 2021 (GLOBE NEWSWIRE) - Bespoke Extracts, Inc. (OTC: BSPK) (?Bespoke? or the ?Company?), a company focusing on consumer products in CBD and regulated cannabis, today signed definitive documents to acquire

November 29, 2021 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING

NT 10-K 1 ea151472-nt10kbespoke.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ýForm 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: August 31, 2021 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on For

November 29, 2021 SC 13D

BSPK / Bespoke Extracts Inc / FEINSOD MICHAEL - SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC.

November 23, 2021 SC 13D/A

BSPK / Bespoke Extracts Inc / Pollack Danil - AMENDMENT NO.5 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

November 22, 2021 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2021 Bespoke Extracts, Inc.

November 3, 2021 SC 14F1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT Pursuant to Section 14(F) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder BESPOKE EXTRACTS, INC. (Exact name of registrant as

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT Pursuant to Section 14(F) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder BESPOKE EXTRACTS, INC. (Exact name of registrant as specified in its charter) 000-52759 (Commission File Number) Nevada 20-4743354 (State or other jurisdiction of incorporation or organization) (I.R.S.

October 29, 2021 EX-10.2

Cancellation and Satisfaction of Debenture Agreement by and between Bespoke Extracts, Inc. and Berique Labs, LLC

Exhibit 10.2 CANCELLATION AND SATISFACTION OF DEBENTURE DATE: OCTOBER 28, 2021 LENDER: BERIQUE LABS, LLC BORROWER: BESPOKE EXTRACTS, INC. ORIGINAL PRINCIPAL AMOUNT: $400,000 WHEREAS, Berique Labs, LLC, a Florida limited liability company (the ?Lender?) is the holder of a Convertible Debenture, issued by Bespoke Extracts, Inc., a Nevada corporation (the ?Borrower?) with an original issue date of De

October 29, 2021 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2021 Bespoke Extracts, Inc.

October 29, 2021 EX-10.1

Stock Purchase Agreement by and among between Bespoke Extracts, Inc., Danil Pollack, and Infinity Management, LLC

Exhibit 10.1 STOCK PURCHASE AGREEMENT by and among BESPOKE EXTRACTS, INC. as Company, DANIL POLLACK as Seller, and INFINITY Management, LLC as Buyer dated as of October 28, 2021 TABLE OF CONTENTS Page ARTICLE I Definitions 1 Section 1.01 Defined Terms 1 ARTICLE II Purchase and Sale 2 Section 2.01 Purchase and Sale 2 Section 2.02 Purchase Price 3 Section 2.03 Cancellation and Satisfaction of Debent

August 17, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: May 31, 2021 ☐ TRANSITION REPORT PURSUANT TO S

10-Q 1 f10q0521bespoke.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: May 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission

August 6, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2021 Bespoke Extracts, Inc.

August 6, 2021 EX-10.2

Amendment No. 6 to Debenture between the Company and Berique Labs LLC

Exhibit 10.2 AMENDMENT NO. 6 TO DEBENTURE This Amendment No. 6 to Debenture (this ?Amendment?) dated this 2nd day of August, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and Berlique Labs LLC (the ?Holder?). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outstanding principal amount of $400

August 6, 2021 EX-10.1

Amendment No. 6 to Debenture between the Company and The Vantage Group Ltd.

Exhibit 10.1 AMENDMENT NO. 6 TO DEBENTURE This Amendment No. 6 to Debenture (this ?Amendment?) dated this 2nd day of August, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and The Vantage Group Ltd., a Delaware corporation (the ?Holder?). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outstan

July 16, 2021 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: May 31, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10-Q

July 8, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2021 Bespoke Extracts, Inc.

April 27, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2021 Bespoke Extracts, Inc.

April 27, 2021 EX-10.1

Amendment No. 2 to Employment Agreement

Exhibit 10.1 AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT This Amendment No. 2 to Employment Agreement (this ?Amendment?) dated this 27th day of April, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and Danil Pollack (the ?Executive?). WHEREAS, the Company and Executive are party to an employment agreement, dated April 22, 2020, as amended by amendment No. 1 thereto, da

April 20, 2021 EX-10.2

Amendment No. 5 to Debenture between the Company and Berique Labs LLC*

Exhibit 10.2 AMENDMENT NO. 5 TO DEBENTURE This Amendment No. 5 to Debenture (this ?Amendment?) dated this 20th day of April, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and Berlique Labs LLC (the ?Holder?). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outstanding principal amount of $400

April 20, 2021 EX-10.1

Amendment No. 5 to Debenture between the Company and The Vantage Group Ltd.*

Exhibit 10.1 AMENDMENT NO. 5 TO DEBENTURE This Amendment No. 5 to Debenture (this ?Amendment?) dated this 20th day of April, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and The Vantage Group Ltd., a Delaware corporation (the ?Holder?). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outstan

April 20, 2021 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: February 28, 2021 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

April 14, 2021 NT 10-Q

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ?Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: February 28, 2021 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 1

February 24, 2021 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2021 Bespoke Extracts, Inc.

February 24, 2021 EX-10.1

Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of February 24, 2021, between Bespoke Extracts, Inc., a Nevada corporation (the ?Company?), and Valeri Baratov (the ?Purchaser?). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Secu

February 4, 2021 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

January 21, 2021 SC 13D/A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. 4) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC. (Name of I

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

January 21, 2021 EX-10.1

Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of January 21, 2021, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Danil Pollack, an individual (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section

January 21, 2021 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 21, 2021 Bespoke Extracts, Inc.

January 19, 2021 EX-10.1

Amendment No. 4 to Debenture between the Company and The Vantage Group Ltd.

Exhibit 10.1 AMENDMENT NO. 4 TO DEBENTURE This Amendment No. 4 to Debenture (this “Amendment”) dated this 15th day of January, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and The Vantage Group Ltd., a Delaware corporation (the “Holder”). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outst

January 19, 2021 EX-10.2

Amendment No. 4 to Debenture between the Company and Berique Labs LLC

Exhibit 10.2 AMENDMENT NO. 4 TO DEBENTURE This Amendment No. 4 to Debenture (this “Amendment”) dated this 15th day of January, 2021, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Berique Labs LLC, a Delaware corporation (the “Holder”). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outstanding

January 19, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 15, 2021 Bespoke Extracts, Inc.

January 14, 2021 NT 10-Q

- NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ¨Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: November 30, 2020 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 1

January 7, 2021 SC 13D/A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. 3) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC. (Name of I

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

December 30, 2020 SC 13D/A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No. 1) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC. (Name of I

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

December 18, 2020 EX-4.1

Description of Registrant’s Securities (incorporated by reference to 10-K filed December 18, 2020)

Exhibit 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Bespoke Extracts, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, which is the Company’s common stock, $0.001 par value per share. Description of Common Stock The authorized capital stock of

December 18, 2020 10-K

Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (Exa

December 11, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 10, 2020 Bespoke Extracts, Inc.

December 11, 2020 EX-10.1

Amendment No. 3 to Debenture between the Company and The Vantage Group Ltd.

Exhibit 10.1 AMENDMENT NO. 3 TO DEBENTURE This Amendment No. 3 to Debenture (this “Amendment”) dated this 10th day of December, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and The Vantage Group Ltd., a Delaware corporation (the “Holder”). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outs

December 11, 2020 EX-10.2

Amendment No. 3 to Debenture between the Company and Berique Labs LLC

Exhibit 10.2 AMENDMENT NO. 3 TO DEBENTURE This Amendment No. 3 to Debenture (this “Amendment”) dated this 10th day of December, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Berique Labs LLC (the “Holder”). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, in the outstanding principal amount of $4

December 4, 2020 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2020 Bespoke Extracts, Inc.

December 4, 2020 SC 13D/A

BSPK / Bespoke Extracts, Inc. / Pollack Danil - AMENDMENT NO. 2 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

December 4, 2020 EX-10.1

Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 1, 2020, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Danil Pollack, an individual (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section

November 30, 2020 NT 10-K

- NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ýForm 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: August 31, 2020 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨ Transition Report on F

November 17, 2020 SC 13D/A

BSPK / Bespoke Extracts, Inc. / Pollack Danil - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

November 12, 2020 EX-10.1

Exchange Agreement between Bespoke Extracts, Inc. and Danil Pollack

Exhibit 10.1 EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) dated this 10th day of November, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Danil Pollack, an individual (the “Holder”). WHEREAS, the Holder is the holder of a promissory note, dated August 31, 2020, in the outstanding principal amount of $150,000 (the “Note”) of the Company; WHEREAS

November 12, 2020 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2020 Bespoke Extracts, Inc.

October 19, 2020 EX-10.1

Consulting Agreement

Exhibit 10.1 CONSULTING AGREEMENT THIS CONSULTING AGREEMENT (this “Agreement”) is made on October 12, 2020 by and between Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Yaniv Rozen (the “Executive”). WHEREAS, the Company wishes to engage the Executive pursuant to the terms and conditions of this Agreement and Executive wishes to be engaged by the Company pursuant to the terms and

October 19, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 13, 2020 Bespoke Extracts, Inc.

October 7, 2020 EX-3.1

Certificate of Amendment to Articles of Incorporation (incorporated by reference to 8-K filed October 7, 2020)

Exhibit 3.1

October 7, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2020 Bespoke Extracts, Inc.

October 1, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2020 Bespoke Extracts, Inc.

October 1, 2020 EX-10.1

Amendment No. 1 to Employment Agreement

Exhibit 10.1 AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT This Amendment No. 1 to Employment Agreement (this “Amendment”) dated this 30th day of September, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Danil Pollack (the “Executive”). WHEREAS, the Company and Executive are party to an employment agreement, dated April 22, 2020 (the “Employment Agreement”); WHEREAS,

September 28, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 31, 2020 Bespoke Extracts, Inc.

September 28, 2020 EX-10.1

Promissory Note

Exhibit 10.1 $150,000 August 31, 2020 PROMISSORY NOTE FOR VALUE RECEIVED, Bespoke Extracts, Inc., a Nevada corporation (the “Company”) hereby promises to pay to Danil Pollack (“Holder”), in lawful money of the United States of America, the principal sum of One Hundred Fifty Thousand Dollars ($150,000), on November 30, 2020 (the “Maturity Date”). This Note will not bear interest. The Company shall

September 25, 2020 8-K/A

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - AMENDMENT NO. 1 TO FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A (Amendment No.

September 8, 2020 DEF 14C

- DEFINITIVE INFORMATION STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: £ Preliminary Information Statement £ Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) S Definitive Information Statement Bespoke Extracts, I

September 1, 2020 8-K

Submission of Matters to a Vote of Security Holders

8-K 1 ea126303-8kbespoke.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 26, 2020 Bespoke Extracts, Inc. (Exact name of registrant as specified in its charter) Nevada 000-52759 20-4743354 (State or other jur

August 26, 2020 EX-10.1

Amendment No. 2 to Debenture

Exhibit 10.1 AMENDMENT NO. 2 TO DEBENTURE This Amendment No. 2 to Debenture (this “Amendment”) dated this 21st day of August, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and The Vantage Group Ltd., a Delaware corporation (the “Holder”). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, dated Decembe

August 26, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits - CURRENT REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 21, 2020 Bespoke Extracts, Inc.

August 26, 2020 PRE 14C

- PRELIMINARY INFORMATION STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 (Amendment No. ) Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14A-6(e)(2)) ¨ Definitive Information Statement Bespoke Extracts, I

July 9, 2020 10-Q

Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: May 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, INC

July 2, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2020 Bespoke Extracts, Inc.

July 2, 2020 EX-3.1

Certificate of Withdrawal of Certificate of Designation

Exhibit 3.1

June 25, 2020 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2020 Bespoke Extracts, Inc.

June 5, 2020 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2020 Bespoke Extracts, Inc.

June 2, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2020 Bespoke Extracts, Inc.

June 2, 2020 EX-10.1

Amendment No. 1 to Debenture

Exhibit 10.1 AMENDMENT NO. 1 TO DEBENTURE This Amendment No. 1 to Debenture (this “Amendment”) dated this 28th day of May, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and The Vantage Group Ltd., a Delaware corporation (the “Holder”). WHEREAS, the Holder is the holder of an outstanding original issue discount convertible debenture of the Company, dated December 2

May 22, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 ea122297-8kbespokeextracts.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2020 Bespoke Extracts, Inc. (Exact name of registrant as specified in its charter) Nevada 000-52759 20-4743354 (State or othe

May 1, 2020 SC 14F1

- SCHEDULE 14F-1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT Pursuant to Section 14(F) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder BESPOKE EXTRACTS, INC. (Exact name of registrant as specified in its charter) 000-52759 (Commission File Number) Nevada 20-4743354 (State or other jurisdiction of incorporation or organization) (I.R.S.

April 30, 2020 SC 13D

BSPK / Bespoke Extracts, Inc. / Pollack Danil - SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC.

April 29, 2020 EX-10.1

Amendment No. 1 to Security Agreement

Exhibit 10.1 AMENDMENT NO. 1 TO SECURITY AGREEMENT This Amendment No. 1 to Security Agreement (this “Amendment”) dated this 23rd day of April, 2020, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and The Vantage Group Ltd., a Delaware corporation (the “Holder”). WHEREAS, the Holder, as purchaser from the original holder of an original issue discount convertible debenture

April 29, 2020 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2020 Bespoke Extracts, Inc.

April 23, 2020 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 16, 2020 Bespoke Extracts, Inc.

April 23, 2020 EX-10.2

Employment Agreement between Bespoke Extracts, Inc. and Danil Pollack

Exhibit 10.2 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made on April 22, 2020 by and between Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Danil Pollack (the “Executive”). WHEREAS, the Company wishes to employ the Executive pursuant to the terms and conditions of this Agreement and Executive wishes to be employed by the Company pursuant to the terms an

April 23, 2020 EX-10.1

Letter Agreement between Bespoke Extracts, Inc. and Niquana Noel

Exhibit 10.1 Bespoke Extracts, Inc. 323 Sunny Isles Boulevard, Suite 700 Sunny Isles Beach, FL 33160 April 16, 2020 To Bespoke Extracts, Inc.: Reference is hereby made to the warrant agreement, dated on or about October 30, 2018 (the “Warrant Agreement”), pursuant to which the undersigned was issued 20,000,000 shares (the “Warrant Shares”) of common stock of the Company. The undersigned hereby wai

April 9, 2020 10-Q

BSPK / Bespoke Extracts, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: February 29, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

March 26, 2020 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2020 Bespoke Extracts, Inc.

March 26, 2020 EX-10.1

Letter Agreement between Bespoke Extracts, Inc. and Niquana Noel

Exhibit 10.1 March 25, 2020 Bespoke Extracts, Inc. 323 Sunny Isles Boulevard, Suite 700 Sunny Isles Beach, FL 33160 Ladies and Gentlemen: I hereby exchange 1 outstanding share of Series B Preferred Stock of Bespoke Extracts, Inc. (the “Company”) in exchange for 1 newly created share of Series C Preferred Stock of the Company, such exchange to be effective upon the Company’s filing of the Certifica

March 26, 2020 EX-3.1

Certificate of Designation of Series C Preferred Stock (incorporated by reference to 8-K filed March 26, 2020)

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF BESPOKE EXTRACTS, INC. ESTABLISHING THE DESIGNATIONS, PREFERENCES, LIMITATIONS AND RELATIVE RIGHTS OF ITS SERIES C PREFERRED STOCK Bespoke Extracts, Inc. (the “Company”), a corporation organized and existing under the laws of Nevada, does hereby certify that, pursuant to authority conferred upon the Board of Directors of the Company by the Articles of Inco

January 21, 2020 10-Q

DIMI / DiMi Telematics International, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

January 14, 2020 NT 10-Q

DIMI / DiMi Telematics International, Inc. NT 10-Q - - NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: November 30, 2019 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form

December 31, 2019 EX-10.2

Original Issue Discount Convertible Debenture dated December 24, 2019 (incorporated by reference to 8-K filed December 31, 2019)

Exhibit 10.2 THE ISSUANCE AND SALE OF THIS DEBENTURE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE DEBENTURE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE DEBENTURE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN AVAILABLE EXEMPTION FROM REGIST

December 31, 2019 EX-10.1

Securities Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2019, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Anthony Ivankovich, an individual (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Se

December 31, 2019 EX-10.4

Repayment Agreement

Exhibit 10.4 Agreement Agreement, dated December 24, 2019, between Bespoke Extracts, Inc. (the “Company”) and Yad Zahav LLC, a New York limited liability company (the “Holder”). WHEREAS, on or about November 11, 2019, the Company issued to the Holder an amended and restated original issue discount convertible debenture, in the principal amount of $200,000 (the “Debenture”); WHEREAS, the Company an

December 31, 2019 EX-10.3

Security Agreement

Exhibit 10.3 SECURITY AGREEMENT SECURITY AGREEMENT (this “Agreement”), dated as of December 24, 2019, by and among Bespoke Extracts, Inc., a Nevada corporation (“Company”), and Anthony Ivankovich, an individual (the “Secured Party”). W I T N E S S E T H: WHEREAS, pursuant to a Securities Purchase Agreement between the Company and the Secured Party (the “Purchase Agreement”), the Company has agreed

December 31, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 24, 2019 Bespoke Extracts, Inc.

December 16, 2019 10-K

DIMI / DiMi Telematics International, Inc. 10-K - Annual Report - ANNUAL REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (Exa

December 16, 2019 EX-4.1

Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

EXHIBIT 4.1 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 Bespoke Extracts, Inc. (the “Company”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended, which is the Company’s common stock, $0.001 par value per share. Description of Common Stock The authorized capital stock of

December 2, 2019 NT 10-K

DIMI / DiMi Telematics International, Inc. NT 10-K - - NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10

November 12, 2019 EX-10.1

Amended and Restated Original Issue Discount Convertible Debenture

Exhibit 10.1 THE ISSUANCE AND SALE OF THIS DEBENTURE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE DEBENTURE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE DEBENTURE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN AVAILABL EXEMPTION FROM REGISTR

November 12, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2019 Bespoke Extracts, Inc.

November 8, 2019 EX-10.1

Securities Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of November 6, 2019, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Yad Zahav LLC, a New York limited liability company (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration r

November 8, 2019 EX-10.2

ORIGINAL ISSUE DISCOUNT CONVERTIBLE DEBENTURE

Exhibit 10.2 THE ISSUANCE AND SALE OF THIS DEBENTURE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE DEBENTURE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE DEBENTURE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN AVAILABL EXEMPTION FROM REGISTR

November 8, 2019 EX-10.3

Security Agreement

Exhibit 10.3 SECURITY AGREEMENT SECURITY AGREEMENT (this “Agreement”), dated as of November 6, 2019, by and among Bespoke Extracts, Inc., a Nevada corporation (“Company”), and Yad Zahav LLC(the “Secured Party”). W I T N E S S E T H: WHEREAS, pursuant to a Securities Purchase Agreement between the Company and the Secured Party (the “Purchase Agreement”), the Company has agreed to sell and issue to

November 8, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2019 Bespoke Extracts, Inc.

October 21, 2019 EX-10.1

Securities Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of October 14, 2019, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Ronald Smith, an individiaul (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section

October 21, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 14, 2019 Bespoke Extracts, Inc.

October 4, 2019 EX-3.1

Certificate of Designation of Series B Preferred Stock

Exhibit 3.1 CERTIFICATE OF DESIGNATION OF BESPOKE EXTRACTS, INC. ESTABLISHING THE DESIGNATIONS, PREFERENCES, LIMITATIONS AND RELATIVE RIGHTS OF ITS SERIES B PREFERRED STOCK Bespoke Extracts, Inc. (the “Company”), a corporation organized and existing under the laws of Nevada, does hereby certify that, pursuant to authority conferred upon the Board of Directors of the Company by the Articles of Inco

October 4, 2019 EX-10.1

Letter Agreement between Bespoke Extracts, Inc. and Niquana Noel

Exhibit 10.1 October 3, 2019 Bespoke Extracts, Inc. 323 Sunny Isles Boulevard, Suite 700 Sunny Isles Beach, FL 33160 Ladies and Gentlemen: I hereby exchange $24,000 of accrued but unpaid compensation owed to me by Bespoke Extracts, Inc. (the “Company”) in exchange for 1 newly created share of Series B Preferred Stock of the Company, such exchange to be effective upon the Company’s filing of the Ce

October 4, 2019 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 3, 2019 Bespoke Extracts, Inc.

July 26, 2019 10-Q

DIMI / DiMi Telematics International, Inc. 10-Q - Quarterly Report - QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: May 31, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, INC

July 22, 2019 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 19, 2019 Bespoke Extracts, Inc.

July 22, 2019 EX-99.1

NON-BINDING TERM SHEET

Exhibit 99.1 NON-BINDING TERM SHEET This Preliminary Term Sheet (this “Term Sheet”) is an expression of interest only and is not meant to be binding on the parties now or in the future. Accordingly, the parties understand and agree that unless and until a definitive agreement (the “Acquisition Agreement”) has been executed by Cannasaver Corp. and its shareholders (the “Company”) and Bespoke Extrac

July 15, 2019 NT 10-Q

DIMI / DiMi Telematics International, Inc. NT 10-Q - - NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: May 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q

June 26, 2019 EX-99.1

EXCHANGE AGREEMENT

Exhibit 99.1 Exhibit 99.1 EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) dated this 22th day of April, 2019, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and McGlothlin Holdings, Ltd. (the “Holder”). W I T N E S S E T H: WHEREAS, the Holder is the holder of a (i) convertible debenture of the Company, in the original principal amount of $540,000, issued o

June 26, 2019 SC 13D

DIMI / DiMi Telematics International, Inc. / McGlothlin Holdings, Ltd. Activist Investment

Bespoke Extracts, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Bespoke Extracts, Inc (Name of Issuer) Common Stock, Par Value $0.001 Per Share (Title of Class of Securities) (CUSIP Number) Stan Mcglothlin, Mcglothlin Holdings, Ltd. PO Box 590, Luling, Texas 78649, 830-875-6927 (Name, Address and

June 7, 2019 EX-16.1

Letter from MaloneBailey, LLP (incorporated by reference to 8-K filed June 7, 2019)

Exhibit 16.1 June 7, 2019 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements under Item 4.01 of the Current Report on Form 8-K of Bespoke Extracts, Inc. to be filed with the Securities and Exchange Commission on or about June 6, 2019. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with the other

June 7, 2019 8-K

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2019 Bespoke Extracts, Inc.

May 1, 2019 10-Q

DIMI / DiMi Telematics International, Inc. 10-Q Quarterly Report QUARTERLY REPORT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: February 28, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

April 23, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2019 Bespoke Extracts, Inc.

April 23, 2019 EX-10.1

Exchange Agreement between the Company and McGlothlin

Exhibit 10.1 EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) dated this 22nd day of April, 2019, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and McGlothlin Holdings, Ltd. (the “Holder”). W I T N E S S E T H: WHEREAS, the Holder is the holder of a (i) convertible debenture of the Company, in the original principal amount of $540,000, issued on or about Ap

April 23, 2019 EX-10.2

Exchange Agreement between the Company and Alneil

Exhibit 10.2 EXCHANGE AGREEMENT This Exchange Agreement (this “Agreement”) dated this 22nd day of April, 2019, by and among Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Alneil Associates (the “Holder”). W I T N E S S E T H: WHEREAS, the Holder is the holder of a (i) convertible debenture of the Company, in the original principal amount of $180,000, issued on or about September

April 15, 2019 NT 10-Q

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: February 28, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form

April 9, 2019 EX-10.1

Securities Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of April 1, 2019, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Daniel Surginer, an individual (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5

April 9, 2019 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2019 Bespoke Extracts, Inc.

February 25, 2019 8-K

Unregistered Sales of Equity Securities

8-K 1 f8k022119bespoke.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 21, 2019 Bespoke Extracts, Inc. (Exact name of registrant as specified in its charter) Nevada 000-52759 20-4743354 (State or other jur

January 23, 2019 10-Q

DIMI / DiMi Telematics International, Inc. QUARTERLY REPORT (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

January 14, 2019 NT 10-Q

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: November 30, 2018 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form

December 14, 2018 10-K

Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (Exa

December 14, 2018 EX-14.1

Code of Ethics (incorporated by reference to 10-K filed December 14, 2018)

EX-14.1 2 f10k2018ex14-1bespoke.htm CODE OF ETHICS Exhibit 14.1 Code of Ethics Bespoke Extracts, Inc. (the “Company”) has adopted this Code of Ethics (“Code”) for the following purposes: to deter wrongdoing and to promote the honest and ethical conduct of all the Company’s employees, including the ethical handling of actual or apparent conflicts of interest between personal and professional relati

November 29, 2018 NT 10-K

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

NT 10-K 1 extf10k2018bespoke.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ýForm 10-K ¨ Form 20-F ¨ Form 11-K ¨ Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: August 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ T

November 26, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 25, 2018 Bespoke Extracts, Inc.

November 15, 2018 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2018 Bespoke Extracts, Inc.

November 14, 2018 SC 14F1/A

DIMI / DiMi Telematics International, Inc. AMENDMENT NO. 1 TO FORM SC 14F1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14F-1/A (Amendment No. 1) INFORMATION STATEMENT Pursuant to Section 14(F) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder BESPOKE EXTRACTS, INC. (Exact name of registrant as specified in its charter) 000-52759 (Commission File Number) Nevada 20-4743354 (State or other jurisdiction of incorporation or o

November 13, 2018 SC 14F1

DIMI / DiMi Telematics International, Inc. INFORMATION STATEMENT

SC 14F1 1 sc14f11118bespokeextracts.htm INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT Pursuant to Section 14(F) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder BESPOKE EXTRACTS, INC. (Exact name of registrant as specified in its charter) 000-52759 (Commission File Number) Nevada 20-4743354 (State o

November 13, 2018 SC 13D/A

BSPK / Bespoke Extracts, Inc. / Yahr Marc - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Amendment No.

November 8, 2018 SC 13D

BSPK / Bespoke Extracts, Inc. / Noel Niquana Monique - SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC.

November 2, 2018 EX-10.1

Employment Agreement between the Company and Niquana Noel (incorporated by reference to 8-K filed November 2, 2018) **

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made on October , 2018 by and between Bespoke Extracts, Inc., a Nevada corporation (the “Company”) and Niquana Noel (the “Executive”). WHEREAS, the Company wishes to employ the Executive pursuant to the terms and conditions of this Agreement and Executive wishes to be employed by the Company pursuant to the terms and

November 2, 2018 EX-4.1

Form of Warrant

Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, (II) SU

November 2, 2018 8-K

Changes in Control of Registrant, Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2018 Bespoke Extracts, Inc.

October 23, 2018 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2018 Bespoke Extracts, Inc.

October 12, 2018 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 11, 2018 Bespoke Extracts, Inc.

July 20, 2018 10-Q

DIMI / DiMi Telematics International, Inc. QUARTERLY REPORT (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: May 31, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, INC

July 16, 2018 NT 10-Q

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ¨Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: May 31, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 10-Q ¨

June 15, 2018 8-K

Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2018 Bespoke Extracts, Inc.

June 4, 2018 8-K

Unregistered Sales of Equity Securities

8-K 1 f8k052918bespokeextracts.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2018 Bespoke Extracts, Inc. (Exact name of registrant as specified in its charter) Nevada 000-52759 20-4743354 (State or other

May 3, 2018 10-Q

DIMI / DiMi Telematics International, Inc. QUARTERLY REPORT (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: February 28, 2018 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

May 3, 2018 EX-10.1

Convertible Debenture, dated December 13, 2017*

EXHIBIT 10.1 THE ISSUANCE AND SALE OF THIS DEBENTURE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE DEBENTURE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE DEBENTURE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL S

April 16, 2018 NT 10-Q

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ¨Form 10-K ¨ Form 20-F ¨ Form 11-K ý Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: February 28, 2018 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 1

March 14, 2018 EX-10.1

Asset Purchase Agreement

Exhibit 10.1 ASSET PURCHASE AGREEMENT THIS ASSET PURCHASE AGREEMENT (the “Agreement”) is made as of March 9, 2018 (the “Effective Date”), by and between VMI Acquisitions, LLC, a Delaware limited liability company (the “Buyer”) and Bespoke Extracts, Inc., a Nevada corporation (the “Seller”). RECITALS WHEREAS, Seller is the lawful owner of a proprietary Machine-to-Machine communications solution (“D

March 14, 2018 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 9, 2018 Bespoke Extracts, Inc.

March 8, 2018 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2018 Bespoke Extracts, Inc.

March 8, 2018 EX-10.1

Form of Purchase Agreement

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of March 5, 2018, between Bespoke Extracts, Inc., a Nevada corporation (the “Company”), and Ocean M Ltd. (the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities

January 22, 2018 10-Q

DIMI / DiMi Telematics International, Inc. QUARTERLY REPORT (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS

January 16, 2018 NT 10-Q

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number000-52759 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: November 30, 2017 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transition Report on Form 1

December 21, 2017 10-K

DIMI / DiMi Telematics International, Inc. ANNUAL REPORT (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2017 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-52759 BESPOKE EXTRACTS, INC. (Exa

December 1, 2017 NT 10-K

DIMI / DiMi Telematics International, Inc. NOTIFICATION OF LATE FILING

NT 10-K 1 extf10k17bespoke.htm NOTIFICATION OF LATE FILING SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number 000-52759 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2017 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 10-Q ☐ Transition Repor

September 7, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 f8k090617bespoke.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 6, 2017 Bespoke Extracts, Inc. (Exact name of registrant as specified in its charter) Nevada 000-52759 20-4743354 (State or other jurisdict

July 18, 2017 SC 14F1

DiMi Telematics International INFORMATION STATEMENT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 SCHEDULE 14F-1 INFORMATION STATEMENT Pursuant to Section 14(F) of the Securities Exchange Act of 1934 and Rule 14f-1 thereunder BESPOKE EXTRACTS, INC. (Exact name of registrant as specified in its charter) 000-52759 (Commission File Number) Nevada 22-1831409 (State or other jurisdiction of incorporation or organization) (I.R.S.

July 18, 2017 10-Q

DIMI / DiMi Telematics International, Inc. QUARTERLY REPORT (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: May 31, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-52759 BESPOKE EXTRACTS, INC

July 17, 2017 NT 10-Q

DiMi Telematics International NOTIFICATION OF LATE FILING

NT 10-Q 1 extf10q0517bespokeextract.htm NOTIFICATION OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number000-52759 NOTIFICATION OF LATE FILING (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: May 31, 2017 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F

June 1, 2017 SC 13D

BSPK / Bespoke Extracts, Inc. / Yahr Marc - SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 08634Q109 (CUSIP Number) Marc Yahr 301 Yamato Road, Suite 1240 Boca Raton, FL 33431

May 31, 2017 EX-99.1

SUBSCRIPTION AGREEMENT

EXHIBIT 99.1 SUBSCRIPTION AGREEMENT This Subscription Agreement (this “Subscription Agreement”) is being delivered to the purchaser identified on the signature page to this Agreement (the “Subscriber”) in connection with its investment in Bespoke Extracts, Inc., a Nevada corporation (the “Company”). The Company is conducting a private placement (the “Offering”) of units (“Units”) in an amount up t

May 31, 2017 SC 13D/A

DIMI / DiMi Telematics International, Inc. / McGlothlin Holdings, Ltd. Activist Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 Bespoke Extacts, Inc.

May 31, 2017 EX-99.2

CONVERTIBLE DEBENTURE

EXHIBIT 99.2 THE ISSUANCE AND SALE OF THIS DEBENTURE HAS BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE DEBENTURE MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE DEBENTURE UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL S

May 31, 2017 EX-99.3

BESPOKE EXTRACTS, INC.

EXHIBIT 99.3 WARRANT NO. BESPOKE EXTRACTS, INC. 900,000 Shares WARRANT TO PURCHASE COMMON STOCK VOID AFTER 5:30 P.M., EASTERN TIME, ON THE EXPIRATION DATE THIS WARRANT AND ANY SHARES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, PLEDGED, HYPOTHECATED, DONATED OR OTHERWISE TRANSFERRED WITHOUT COMPLI

May 26, 2017 EX-4.1

Form of Warrant

Exhibit 4.1 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND, ACCORDINGLY, MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE SECURITIES ACT OF 1933, AS AMENDED, (II) SU

May 26, 2017 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 22, 2017 Bespoke Extracts, Inc.

May 26, 2017 EX-10.1

Marc Yahr Employment Agreement

Exhibit 10.1 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (this ?Agreement?) is made on May 22, 2017 by and between Bespoke Extracts, Inc., a Nevada corporation (the ?Company?) and Marc Yahr (the ?Executive?). WHEREAS, the Company wishes to employ the Executive pursuant to the terms and conditions of this Agreement and Executive wishes to be employed by the Company pursuant to the terms and cond

May 24, 2017 SC 13D/A

BSPK / Bespoke Extracts, Inc. / TENZER BARRY - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) BESPOKE EXTRACTS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 08634Q109 (CUSIP Number) Barry Tenzer 301 Yamato Road, Suite 1240

April 19, 2017 10-Q

DiMi Telematics International QUARTERLY REPORT (Quarterly Report)

10-Q 1 f10q0217bespokeextracts.htm QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: February 28, 2017 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from t

April 17, 2017 NT 10-Q

DiMi Telematics International NOTIFICATION OF LATE FILING

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 Commission File Number: 000-52759 NOTIFICATION OF LATE FILING ? Form 10-K ? Form 11-K ? Form 20-F ? Form 10-Q ? Form N-SAR For Period Ended: February 28, 2017 ? Transition Report on Form 10-K ? Transition Report on Form 10-Q ? Transition Report on Form 20-F ? Transition Report on Form N-SAR For the Transition Period Ended: Nothi

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista